OncoGenex Pharmaceuticals Lands $9,500,000 New Funding

  • Feed Type
  • Date
    7/20/2009
  • Company Name
    OncoGenex Pharmaceuticals
  • Mailing Address
    1522 217th Place SE Bothell, WA 98021
  • Company Description
    OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. We have a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development.
  • Website
    http://www.oncogenex.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.